Lista de obras - marco bregni - Dominio Público Uruguay

4th Edition of the International Autologous and Allogeneic Cell Therapy for Solid Tumors (ATST) Meeting.

artículo científico publicado en 2011

A dual role for genetically modified lymphocytes in cancer immunotherapy.

artículo científico publicado en 2012

A proportion of patients with lymphoma may harbor mutations of the perforin gene.

artículo científico publicado en 2005

Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC).

artículo científico publicado en 2011

Allogeneic non-myeloablative peripheral-blood stem cell transplant in solid tumors.

artículo científico publicado en 2002

Allogeneic stem cell transplantation for renal cell carcinoma

artículo científico publicado en 2011

Antitumor effects of HSV-TK engineered donor lymphocytes after allogeneic stem-cell transplantation

artículo científico publicado en 2007

Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes

artículo científico publicado en 2012

Current immunotherapy for solid tumors.

artículo científico publicado en 2009

Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina.

artículo científico publicado en 2006

Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

artículo científico publicado en 2009

Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.

artículo científico publicado en 2004

High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Transplantation in Metastatic Breast Cancer: Overview of Six Randomized Trials ⬇️

artículo científico publicado el 18 de julio de 2011

High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.

artículo científico publicado en 2011

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

artículo científico publicado en 2009

Inherited Perforin andFasMutations in a Patient with Autoimmune Lymphoproliferative Syndrome and Lymphoma

Innovative Platforms for Haploidentical Stem Cell Transplantation: The Role of Unmanipulated Donor Graft ⬇️

artículo científico publicado el 3 de junio de 2011

Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-Hu mice.

artículo científico publicado en 2004

Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer

artículo científico publicado en 2002

Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients

artículo científico publicado en 2008

Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation.

artículo científico publicado en 2005

Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'.

artículo científico publicado en 2008

Reduced intensity conditioning with thiotepa, fludarabine, and melphalan is effective in advanced multiple myeloma

artículo científico publicado en 2007

Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: a survey of different populations.

artículo científico publicado en 2006

Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses

artículo científico publicado en 2009

Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function

article

[Cellular therapies in 2002]

scientific article published on 01 November 2002

Lista de obras de marco bregni

4th Edition of the International Autologous and Allogeneic Cell Therapy for Solid Tumors (ATST) Meeting.

A dual role for genetically modified lymphocytes in cancer immunotherapy.

A proportion of patients with lymphoma may harbor mutations of the perforin gene.

Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC).

Allogeneic non-myeloablative peripheral-blood stem cell transplant in solid tumors.

Allogeneic stem cell transplantation for renal cell carcinoma

Antitumor effects of HSV-TK engineered donor lymphocytes after allogeneic stem-cell transplantation

Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes

Current immunotherapy for solid tumors.

Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina.

Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.

High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Transplantation in Metastatic Breast Cancer: Overview of Six Randomized Trials ⬇️

High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

Inherited Perforin andFasMutations in a Patient with Autoimmune Lymphoproliferative Syndrome and Lymphoma

Innovative Platforms for Haploidentical Stem Cell Transplantation: The Role of Unmanipulated Donor Graft ⬇️

Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-Hu mice.

Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer

Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients

Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation.

Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'.

Reduced intensity conditioning with thiotepa, fludarabine, and melphalan is effective in advanced multiple myeloma

Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: a survey of different populations.

Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses

Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function

[Cellular therapies in 2002]